Updates are available Correction dated 2024-11-25
Click to view Correction: https://doi.org/10.1007/s00403-024-03537-5
-
Authors
Kamminga, N. C.W. https://orcid.org/0000-0002-8386-2540
Kievits, J. E.C.
Wakkee, M. https://orcid.org/0000-0001-8578-901X
Loon, S. G.W. van https://orcid.org/0009-0000-2255-4184
Joosen, M. C.W. https://orcid.org/0000-0001-5064-7302
Verver, D.
Munte, K. https://orcid.org/0000-0003-3338-0786
Plaisier, P. W.P. https://orcid.org/0009-0006-0501-813X
Rietjens, J. A.C. https://orcid.org/0000-0002-0538-5603
Nijsten, T. E.C. https://orcid.org/0000-0001-9940-2875
Lugtenberg, M. https://orcid.org/0000-0002-4117-2154
-
Funding
Funding for this research was provided by:
Bristol Myers Squibb
Merck Sharp & Dohme
Novartis
Les Laboratories Pierre Fabre
- License Information
-
More Information
Article History
Received: 19 July 2024
Revised: 19 July 2024
Accepted: 4 September 2024
First Online: 26 September 2024
Change Date: 12 November 2024
Change Type: Update
Change Details: The original online version of this article was revised to correct Reference 10.
Change Date: 25 November 2024
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s00403-024-03537-5
Declarations
:
: The Medical Ethics Committee Erasmus MC concluded after review of the study design that the rules laid down in the Medical Research Involving Human Subjects Act (Dutch abbreviation: WMO) did not apply to this study (MEC-2019-0558 and MEC-2020-0197).
: The authors declare no competing interests.
